Nanobiotix (NBTX) Payables (2019 - 2025)

Nanobiotix's Payables history runs 7 years deep, the most recent figure standing at $10.6 million for Q4 2025.

• In Q4 2025, Payables fell 50.41% year-over-year to $10.6 million; the TTM figure through Dec 2025 stood at $10.6 million (down 50.41% YoY), while the FY2025 annual figure was $10.3 million, down 51.87% from the prior year.
• Payables was $10.6 million for Q4 2025 at Nanobiotix, down from $13.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $21.4 million in Q4 2024 to a low of $7.4 million in Q4 2021.
• Historically, Payables has averaged $14.1 million across 5 years, with a median of $11.9 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Payables jumped 99.9% in 2023, then sank 50.41% in 2025.
• A 5-year view of Payables shows it stood at $7.4 million in 2021, then jumped by 32.37% to $9.8 million in 2022, then jumped by 99.9% to $19.6 million in 2023, then rose by 9.11% to $21.4 million in 2024, then tumbled by 50.41% to $10.6 million in 2025.
• The last three Payables figures came in at $10.6 million (Q4 2025), $13.2 million (Q2 2025), and $21.4 million (Q4 2024), per Business Quant data.